Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide

Abstract Introduction Cardiovascular diseases are a leading cause of global mortality, with hypertension as a major risk factor. Low control rates are often attributed to monotherapy, while evidence and clinical guidelines support the effectiveness of combination therapies. This study aimed to evalu...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Isabel E. Rucker-Joerg, Ernesto G. Cardona-Muñoz, Francisco G. Padilla-Padilla, Rodrigo Suarez-Otero, Yulia Romero-Antonio, Emmanuel Canales-Vázquez, Kevin F. Rios-Brito, Ileana C. Rodríguez-Vazquez, Jorge González-Canudas
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2025-04-01
coleção:	Cardiology and Therapy
Assuntos:	Hypertension Cardiovascular disease Losartan Chlorthalidone Hydrochlorothiazide
Acesso em linha:	https://doi.org/10.1007/s40119-025-00407-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!